Skip to main content
. Author manuscript; available in PMC: 2019 Jan 4.
Published in final edited form as: Int J Obes (Lond). 2017 Aug 14;42(4):785–793. doi: 10.1038/ijo.2017.190

Table 2.

Clinical, Behavioral, and Hormonal Characteristics at Baseline and 12-months

Baseline (M±SD) 12-months (M±SD) t p

Weight (lbs.) 256.6 ± 36.2 181.0 ±34.2 14.7 <0.001
BMI 41.8 ± 4.5 29.6 ± 4.0 14.5 <0.001
% Total Weight Loss 29.0 ± 7.7
TFEQ
    Cognitive Restraint of Eating 48.8 ± 24.4 65.4 ± 26.1 −2.2 0.041
    Uncontrolled Eating 59.7 ± 19.6 14.2 ± 4.9 11.8 <0.001
    Emotional Eating 60.2 ± 24.8 27.5 ± 22.4 6.0 <0.001
DEBQ
    Emotional Eating 3.2 ± 0.7 1.9 ± 0.9 6.7 <0.001
    Restrained Eating 3.1 ± 0.7 2.8 ± 1.0 1.5 0.162
    External Eating 3.4 ± 0.5 2.3 ± 0.8 5.3 <0.001
PFS
    Food available 3.0 ± 0.9 1.5 ± 0.7 10.3 <0.001
    Food present 3.7 ± 0.9 2.3 ± 1.2 6.3 <0.001
    Food tasted 3.3 ± 0.9 2.4 ± 0.9 5.2 <0.001
ERQ*
    Cognitive Reappraisal 18.8 ± 9.3 16.2 ± 7.7 1.1 0.284
    Expressive Suppression 17.7 ± 5.8 20.4 ± 5.8 −1.9 0.074
BDI 10.4 ± 6.7 2.8 ± 3.1 4.6 <0.001
STAI Trait Anxiety 40.8 ± 15.1 42.0 ± 10.9 −0.28 0.781
Palatable Food Desire Rating during Enhance* 3.2 ± 0.4 2.6 ± 0.7 4.5 <0.001
Palatable Food Desire Rating during Regulate* 1.7 ± 0.4 1.7 ± 0.4 0.2 0.806
Acyl ghrelin (pg/mL)** 254.9 ± 126.5 79.7 ± 87.9 4.76 <0.001
Leptin (ng/mL)** 29.4 ± 18.7 19.3 ± 10.6 2.08 0.050
Glucose (mg/dL) 96.9 ± 18.8 80.1 ± 5.5 3.76 0.002
Insulin (uIU/mL)** 18.2 ± 10.8 6.1 ± 3.2 5.30 <0.001
*

Data missing for 1 subject at 12-months

**

Data missing for 1 subject at baseline and 2 subjects at 12-months